Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.15 HKD | +1.56% | +17.92% | -8.42% |
Apr. 17 | Innovent Appoints Dr. Nageatte Ibrahim as the Oncology Chief Medical Officer | CI |
Apr. 02 | Hutchmed endometrial cancer treatment application accepted for review | AN |
Sales 2023 | 6.21B 856M 6.7B | Sales 2024 * | 7.52B 1.04B 8.12B | Capitalization | 58.81B 8.12B 63.53B |
---|---|---|---|---|---|
Net income 2023 * | -1.2B -165M -1.29B | Net income 2024 * | -891M -123M -963M | EV / Sales 2023 | 10.2 x |
Net cash position 2023 * | 4.42B 611M 4.78B | Net cash position 2024 * | 4.83B 667M 5.22B | EV / Sales 2024 * | 7.18 x |
P/E ratio 2023 * |
-48.2
x | P/E ratio 2024 * |
-64.3
x | Employees | 4,872 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 93.01% |
1 day | +1.56% | ||
1 week | +17.92% | ||
Current month | +3.85% | ||
1 month | +1.56% | ||
3 months | +17.39% | ||
6 months | -7.45% | ||
Current year | -8.42% |
Managers | Title | Age | Since |
---|---|---|---|
De Chao Yu
CEO | Chief Executive Officer | 61 | 11-04-27 |
Fei You
DFI | Director of Finance/CFO | 45 | Feb. 04 |
Yong-Jun Liu
PSD | President | - | 20-10-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Zieziula
BRD | Director/Board Member | 69 | 22-05-30 |
Charles Cooney
BRD | Director/Board Member | 80 | 15-10-17 |
De Chao Yu
CEO | Chief Executive Officer | 61 | 11-04-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.78% | 2 M€ | -16.59% | - | |
1.77% | 4 M€ | -27.92% | ||
1.09% | 1 M€ | -9.86% | - | |
0.68% | 2 M€ | -14.14% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 39.15 | +1.56% | 7,286,643 |
24-04-25 | 38.55 | +1.05% | 7,877,936 |
24-04-24 | 38.15 | +5.53% | 9,468,453 |
24-04-23 | 36.15 | +6.48% | 8,682,141 |
24-04-22 | 33.95 | +2.26% | 6,874,289 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 04:08 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.42% | 7.99B | |
-4.66% | 87.53B | |
+1.32% | 40.42B | |
-19.27% | 29.48B | |
+57.86% | 25.43B | |
-17.69% | 11.49B | |
-43.00% | 11.3B | |
-9.14% | 11.1B | |
+5.24% | 8.75B | |
+2.29% | 7.67B |
- Stock Market
- Equities
- 1801 Stock